Back to home

Posts from "Issue2" tag

A Record Decrease in Cancer Mortality!

Beth Sandy, MSN, CRNP Beth Sandy, MSN, CRNP

In 2021, the American Cancer Society (ACS) reported a substantial decrease in cancer-related mortality in the United States. This data represents incidence and mortality rates through the 2017-2018 years. The ACS report for 2021 reported a record 2.4% decline in cancer mortality from 2017-2018, ...

Read more

The Roles of Advanced Practice Providers in Cancer Survivorship Clinics

Ellen Mullen RN, PhD, GNP-BC, ANP-C Ellen Mullen RN, PhD, GNP-BC, ANP-C

Since the 2006 publication of From Cancer Patient to Cancer Survivors: Lost in Transition by the Institute of Medicine (IOM) on cancer survivorship, improvements have been made in the care of survivors. According to the report, cancer survivors were “lost in transition” and primary care providers ...

Read more

The Benefit of a Pharmacist-run Oral Chemotherapy Clinic on Prescription Abandonment Rates

Megan B May, PharmD, BCOP & Jeannie Patrick, PharmD, BCOP Megan B May, PharmD, BCOP & Jeannie Patrick, PharmD, BCOP

In 2020, the US Food and Drug Administration (FDA) announced approximately 28 new oral anticancer drug approvals and expanded indications for currently available oral anticancer products on the market.1 This expanding area of oncology requires counseling, financial navigation, education, and ...

Read more

A Proven Strategy of Targeted Therapy: Antibody Drug Conjugates in Cancer Treatment

Samantha Musson, PharmD & Moe Schwartz, PharmD, BCOP Samantha Musson, PharmD & Moe Schwartz, PharmD, BCOP

The term “targeted therapy” in cancer refers to drugs or treatment strategies that direct anticancer treatment to specific genes or proteins that influence the growth, proliferation and/or survival of cancer cells.   Antibody-drug conjugates (ADC) are a targeted strategy that has rapidly evolved in ...

Read more

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2)

Adam Kahleifeh, PharmD Adam Kahleifeh, PharmD

Multiple myeloma (MM) is a neoplasm characterized by the clonal proliferation of plasma cells that remains an incurable disease. The treatment of relapsed or relapsed/refractory MM continues to be a challenge despite numerous therapeutic advances. B-cell maturation antigen (BCMA) is a cell-surface ...

Read more

Oncology PA fellowship FAQ

Yue Jiang, PA-C Yue Jiang, PA-C

“So…you are a PA fellow…what’s that?” During my year as an oncology PA fellow at MD Anderson Cancer Center, this question came up so many times that I decided to put in some thoughts into polishing my answers. Patients and other care team members usually want to gauge how much they can trust me and ...

Read more

Talking to your Patient about Biosimilar Medications

Justin Musco Justin Musco

Background and History Biological products or biologics are typically large, complex molecules made within a living system, such as an animal cell. Biologics are used to diagnose, prevent, treat, and cure diseases or medical conditions. Examples of biologics include therapeutic proteins like ...

Read more

Educating Patients to Be Empowered Shared Decision Makers

Jonathan Cunningham, MPAS, PA-C Jonathan Cunningham, MPAS, PA-C

Several months ago, I went to my primary care physician for the management of high blood pressure. As a medical professional, and an otherwise healthy young adult, I did not like just settling with the diagnosis of idiopathic hypertension. I wanted to find the underlying cause. Thankfully, with the ...

Read more